Retinal Fundus Camera Evaluation

NCT ID: NCT02293174

Last Updated: 2022-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera. While also comparing the images to other manufacturer's retinal cameras

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Normal Healthy Subjects With no Known Ocular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal Healthy Eyes

Willing and able subjects with normal and healthy eyes

Topcon TRC-NW400

Intervention Type DEVICE

Retinal Fundus Camera

TRC-NW8

Intervention Type DEVICE

Retinal Fundus Camera

TRC-NW400

Intervention Type DEVICE

Retinal Fundus Camera

Canon-CR2

Intervention Type DEVICE

Retinal Fundus Camera

Zeiss Visucam PRO

Intervention Type DEVICE

Retinal Fundus Camera

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Topcon TRC-NW400

Retinal Fundus Camera

Intervention Type DEVICE

TRC-NW8

Retinal Fundus Camera

Intervention Type DEVICE

TRC-NW400

Retinal Fundus Camera

Intervention Type DEVICE

Canon-CR2

Retinal Fundus Camera

Intervention Type DEVICE

Zeiss Visucam PRO

Retinal Fundus Camera

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with no known ocular diseases

Exclusion Criteria

* Subjects with known ocular diseases
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Topcon Medical Systems, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Danny Leung

Role: PRINCIPAL_INVESTIGATOR

Clinical Trial Manager

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Topcon Medical Systems, Inc.

Oakland, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TOPCON-003-2014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Functional Assessments in Vision Impairment
NCT06908161 NOT_YET_RECRUITING
Camera Qualification Study
NCT05808699 ACTIVE_NOT_RECRUITING
Retinal Deep Phenotyping.TM
NCT05903664 WITHDRAWN
Comparing 3 Imaging Systems
NCT05022615 COMPLETED